Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Trastuzumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Trastuzumab 150mg powder for solution for infusion vials
0801050ADAAAAAA
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab 420mg powder for solution for infusion vials
0801050ADAAAEAE
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab 600mg/5ml solution for injection vials
0801050ADAAABAB
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab 60mg powder for solution for infusion vials
0801050ADAAAFAF
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab emtansine 100mg inf vials
0801050ADAAACAC
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab emtansine 160mg inf vials
0801050ADAAADAD
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.